// App-Quantinova.ai

180 : Long-term Survival Benefit of Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy

Researchers

Presenter

  • Jignesh Patel

Principal Investigators

  • Perry Elliott

  • Balarama Gundapaneni

  • Benjamin Li

  • Marla Sultan

  • Martha Grogan

Medical Centers

  • Cedars-Sinai Smidt Heart Institute, LA, CA

  • Kings College London, London, United Kingdom

  • Pfizer, Groton, CT

  • Pifzer, NY, NY

  • Mayo Clinic, Rochester, MN

Locations

  • United States

  • United Kingdom

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Transthyretin cardiac amyloidosis

  • Amyloidosis, transthyretin-related

Biomarkers

  • Transthyretin

Drug/Treatment

  • Tafamidis meglumine

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved